Lima Corporate Announces Chief Financial Officer Transition

Wednesday, October 4, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

UDINE, Italy, October 4, 2017 /PRNewswire/ --

Lima Corporate announces that starting from 10th

October 2017, Paolo Riccardi will step down as Chief Financial Officer ("CFO") and Director of Lima Corporate.

     (Logo: http://photos.prnewswire.com/prnh/20150417/739765 )

Paolo

Riccardi spent five years at Lima Corporate and contributed substantially to the strong development of the Company. He has now decided to accept a new opportunity but will continue to support the Lima journey as an Advisor during the transition period.

"Paolo's contribution to Lima Corporate's growth and as well as the Management of the ownership transfer from Ardian to EQT in 2016 was fundamental," said Luigi Ferrari, CEO of Lima Corporate. "I respect Paolo's decision to step down and on behalf of the Management Team and Board, I would like to thank him for his many important contributions to our Company and wish him success in the future," concluded Luigi Ferrari.

Luigi Ferrari will assume the role as interim CFO supported by Paolo Riccardi as an Advisor until a new CFO has been onboarded.

About Lima Corporate  Lima Corporate is a global medical device company providing reconstructive orthopaedic solutions to surgeons who face the challenges of improving the quality of life of their patients. Based in Italy, Lima Corporate is committed to the development of innovative products and procedures to enable surgeons to select ideal solution for every individual patient. Lima Corporate's product range includes large joint revision and primary implants and complete extremities solutions including fixation.

For additional information on the Company, please visit: http://www.limacorporate.com

Limacorporate S.p.A. Via Nazionale, 52 33038 Villanova di San Daniele Udine - Italy T: +39-0432-945-511 E: [email protected]

SOURCE Limacorporate SpA



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook